MRDx BCR-ABL Test, MRDx BCR-ABL Test Software

Bcr/abl1 Monitoring Test

MolecularMD Corporation

The following data is part of a premarket notification filed by Molecularmd Corporation with the FDA for Mrdx Bcr-abl Test, Mrdx Bcr-abl Test Software.

Pre-market Notification Details

Device IDK173492
510k NumberK173492
Device Name:MRDx BCR-ABL Test, MRDx BCR-ABL Test Software
ClassificationBcr/abl1 Monitoring Test
Applicant MolecularMD Corporation 1341 SW Custer Drive Portland,  OR  97219
ContactKevin Hawkins
CorrespondentKevin Hawkins
MolecularMD Corporation 1341 SW Custer Drive Portland,  OR  97219
Product CodeOYX  
CFR Regulation Number866.6060 [🔎]
DecisionSubstantially Equivalent - With Drug (SESD)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2017-11-13
Decision Date2017-12-22

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
B60290100280 K173492 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.